Skip to main content
[Preprint]. 2021 Jul 28:2021.07.26.21261028. [Version 1] doi: 10.1101/2021.07.26.21261028

Figure 2. Severe COVID-19 Outcomes among People with HIV by HIV Disease Markers.

Figure 2.

Panel A. Odds of COVID-19 related hospitalization by HIV markers; Panel B. Odds of COVID-19 related invasive ventilation by HIV markers; Panel C. Odds of COVID-19 related death by HIV markers.

NOTE: all outcomes (hospitalization, invasive ventilation, and death) were defined within 45 days of SARS-CoV-2 infection. Model adjusted for age, sex, race and ethnicity (Black non-Hispanic, Hispanic, white non-Hispanic, others), smoking status (never, ever, unknown), study site, severe liver disease, diabetes, cancer, renal disease, total number of comorbidities (0, 1, 2, ≥3), and study sites.

*HIV markers (CD4 cell counts and HIV viral load) were extracted from EMR from 1 years before to 14 days after COVID-19 diagnosis.